Premier Asian Venture Capital • Founded 2020

Architecting the Future of Technology in Asia

Northern Star Partners stands at the forefront of venture capital excellence, identifying and accelerating transformative technology companies across semiconductors, displays, and biotechnology sectors. We don't just invest—we build enduring partnerships that reshape industries.

130.62
Million USD AUM
70
Portfolio Companies
12
Successful Exits
10.18
Net IRR (%)
NSP
90%
Asia Market Focus
4.2x
Average Multiple
7
IPO Exits
58
Active Investments
15+
Years Combined Experience
Our Foundation

Pioneering Venture Excellence Since 2020

Founded with a vision to bridge the gap between breakthrough Asian innovation and global markets, Northern Star Partners has rapidly established itself as a premier venture capital firm with unparalleled sector expertise and institutional-grade investment processes.

01
Strategic Vision & Market Position

Our strategic vision centers on identifying and nurturing technology companies that possess the potential to fundamentally transform their respective industries. We believe that the convergence of advanced semiconductors, next-generation displays, and revolutionary biotechnology represents the most significant opportunity for value creation in the modern economy.

This focused approach allows us to develop deep expertise in market dynamics, technological trends, and competitive landscapes that generalist investors simply cannot match. Our sector specialization enables us to provide strategic guidance that goes far beyond capital, positioning our portfolio companies for sustained competitive advantage and market leadership.

02
Investment Methodology & Due Diligence

Our investment methodology is built on rigorous due diligence processes that evaluate not only financial metrics but also technological differentiation, market timing, competitive positioning, and management team capabilities. We employ proprietary analytical frameworks developed specifically for our target sectors, leveraging both quantitative models and qualitative assessments.

Each investment decision undergoes comprehensive technical review by our team of industry experts, ensuring that we understand both the immediate potential and long-term implications of the technologies we support. This methodical approach has resulted in a portfolio with significantly above-market performance metrics and a 17.1% successful exit rate.

03
Global Network & Value Creation

Our extensive network spans across major innovation hubs in Asia, North America, and Europe, providing our portfolio companies with access to strategic partnerships, customer relationships, and expansion opportunities that would otherwise be unavailable to emerging companies. We maintain active relationships with over 200 strategic partners across our target sectors.

Through our carefully cultivated relationships with industry leaders, academic institutions, research organizations, and strategic partners, we create value beyond traditional venture capital support, acting as a catalyst for growth and market expansion for every company in our portfolio. Our hands-on approach has accelerated time-to-market by an average of 18 months across our portfolio.

Investment Philosophy

Our Investment Thesis

We invest at the intersection of technological innovation and market opportunity, focusing on companies that possess the potential to create new markets or fundamentally transform existing ones through breakthrough technologies and superior execution.

01
SC

Semiconductor Revolution

The semiconductor industry is experiencing unprecedented transformation driven by artificial intelligence, 5G infrastructure, and Internet of Things applications. We invest in companies developing next-generation chip architectures, advanced packaging technologies, and specialized processors that will power the digital economy of tomorrow.

Our portfolio companies in this sector are addressing critical challenges in power efficiency, processing capabilities, and manufacturing innovation, positioning them at the forefront of technological advancement with proprietary solutions that command premium valuations.

02
DT

Display Innovation

The future of human-computer interaction lies in advanced display technologies that seamlessly integrate into our daily lives. From flexible OLED screens to augmented reality interfaces, we invest in companies that are reimagining how digital information is presented and consumed across industries.

Our investments span automotive displays, wearable technologies, and immersive computing platforms that are creating entirely new user experiences and market categories. These companies are positioned to capture significant value as display technology becomes increasingly central to product differentiation.

03
BT

Biotechnology Frontier

Biotechnology represents one of the most significant opportunities for addressing global health challenges while creating substantial economic value. We focus on companies developing innovative therapeutics, diagnostic technologies, and precision medicine platforms that leverage cutting-edge scientific advances.

Our biotech investments leverage technologies including gene therapy, immunotherapy, and AI-driven drug discovery to accelerate the development of breakthrough treatments and diagnostic solutions. These companies benefit from our deep understanding of regulatory pathways and clinical development processes.

Leadership Excellence

World-Class Investment Team

Our leadership team combines decades of investment experience with deep operational expertise across our target sectors. Each team member has a proven track record of identifying, investing in, and building market-leading technology companies with institutional-grade investment processes.

Seejun Jeong

Chief Executive Officer & Managing Partner
15+
Years Experience
$2B+
Portfolio Value
25+
Investments Led

Seejun brings exceptional expertise in semiconductor and technology investments across Asia-Pacific markets. As founding partner, he has led Northern Star Partners' evolution from startup to industry leader, establishing our reputation for sector expertise and operational excellence. Previously Partner at Korea's leading venture capital firm, managing investments exceeding $500M with multiple successful exits including three IPOs valued over $1B combined.

His operational background at Samsung Electronics provides invaluable industry insight and strategic perspective, having managed strategic partnerships and business development for the company's semiconductor division. Seejun serves on six portfolio company boards and is a frequent speaker at major industry conferences including SEMICON Korea and Asian Venture Capital Journal Annual Conference.

Core Expertise
Semiconductor Technology, Strategic Partnerships, Asian Markets, Business Development, Corporate Governance, M&A Strategy

Jiun Lee

Managing Director, Biotechnology
12+
Years Experience
$500M+
Investments Led
3
IPO Exits

Jiun leads our biotechnology investment practice with unparalleled expertise in healthcare innovation and life sciences. His scientific background combined with investment acumen has resulted in exceptional returns across our biotech portfolio, with investments achieving three successful IPOs and two strategic acquisitions totaling over $1B in value creation.

Former Principal at Mirae Asset Venture Investment, Jiun has deep experience in Asian healthcare markets and regulatory environments. His scientific background includes research positions at leading pharmaceutical companies and extensive work in clinical development processes. PhD in Biochemistry from Yonsei University with expertise in drug discovery and regulatory affairs.

Core Expertise
Biotechnology, Drug Discovery, Healthcare Innovation, Regulatory Affairs, Clinical Development, Precision Medicine

Minyoung Oh

Managing Director, Display Technology
14+
Years Experience
$300M+
Investments Led
18
Portfolio Companies

Minyoung oversees our display technology investments with exceptional insight into consumer electronics and emerging display applications. Her technical expertise and market knowledge have positioned our portfolio at the forefront of display innovation, with companies developing breakthrough technologies in OLED, flexible displays, and next-generation automotive display systems.

Previously held senior positions at LG Display Corporation, where she led strategic investments and partnerships in emerging display technologies including OLED, flexible displays, and automotive display solutions. Her corporate development experience provides unique perspective on technology commercialization and global market dynamics. MS in Materials Science from Seoul National University.

Core Expertise
Display Technology, Consumer Electronics, Materials Science, Technology Commercialization, Market Development, Product Strategy

Seokcheol Jeon

Executive Director, Operations
10+
Years Experience
35+
Companies Supported
15
Markets Expanded

Seokcheol leads our portfolio support and operational excellence initiatives, providing critical guidance to companies as they scale operations and expand internationally. His hands-on approach has accelerated growth across our entire portfolio, with measurable improvements in operational efficiency and market reach resulting in an average 35% reduction in time-to-market for portfolio companies.

Experienced technology executive with proven track record of successful international expansion and operational scaling across Asian markets. Has led business development initiatives resulting in over $200M in strategic partnerships and market expansion opportunities for high-growth technology companies. Fluent in Korean, English, Mandarin Chinese, and Japanese.

Core Expertise
Operations Management, International Expansion, Strategic Partnerships, Business Development, Organizational Scaling, Market Entry
Investment Performance

Track Record of Excellence

Our disciplined investment approach and sector expertise have generated strong returns across market cycles, with consistent outperformance relative to comparable Asian venture capital funds and global sector-focused peers.

TV
Total Value Multiple
1.25x
Current portfolio total value to paid-in capital multiple, reflecting strong unrealized value in active investments with clear paths to liquidity.
IR
Internal Rate of Return
10.18%
Net IRR performance across our venture capital fund, benchmarked against comparable Asian VC funds in the top quartile of performance.
DS
Median Deal Size
$10.12M
Median investment amount across our portfolio, enabling meaningful ownership stakes and board representation for value creation.
ER
Successful Exit Rate
17.1%
Percentage of investments achieving successful exits, including IPOs and strategic acquisitions, significantly above industry average.
Portfolio Value Growth
2020 - 2024
2020 2021 2022 2023 2024
Portfolio Excellence

Investment Portfolio

Our portfolio represents a carefully curated collection of industry-leading companies that are defining the future of technology across our target sectors, with a combined enterprise value exceeding $2.5 billion.

70
Total Investments
58
Active Portfolio
12
Successful Exits
7
IPO Exits
Successful Exit
Biotechnology

ImmuneOncia

Revolutionary immunotherapy company that developed breakthrough T-cell engineering technologies for next-generation cancer treatments. Successfully completed IPO on KOSDAQ in May 2025, representing one of the largest biotech public offerings in Korean market history with strong institutional backing.

$23.27M
Exit Value
4.2x
Return Multiple
Successful Exit
Semiconductors

Fadu

Leading developer of advanced SSD controllers and NAND flash memory solutions serving major technology companies worldwide. Completed highly successful IPO in 2023, establishing itself as a key player in the memory semiconductor ecosystem with proprietary controller technologies.

$150.91M
Exit Value
7.8x
Return Multiple
Successful Exit
Aerospace Technology

Innospace

Innovative aerospace company developing small satellite launch vehicles and space technology solutions for commercial and government clients across Asia. IPO in 2024 established leadership in Asian commercial space sector with proven launch capabilities.

$41.67M
Exit Value
3.1x
Return Multiple
Healthcare Technology

PineTree Therapeutics

Biotechnology company focused on developing novel drug delivery systems and therapeutic solutions for complex medical conditions. Currently advancing multiple candidates through clinical trials with strong preliminary results and clear regulatory pathway.

$17.00M
Latest Round
Series 3
Stage
Enterprise Software

ChargeLab

Leading provider of electric vehicle charging management software, serving charging networks and fleet operators across North America and Asia. Experiencing rapid growth as EV adoption accelerates globally with major automotive partnerships.

$30.00M
Latest Round
Series A
Stage
Entertainment Technology

Rooter

Gaming and entertainment platform connecting millions of users across Asia through innovative social gaming experiences and interactive content. Strong monetization metrics and user engagement with clear path to market leadership.

$16.00M
Latest Round
Series B
Stage
Partnership Opportunities

Partner With Northern Star

We welcome conversations with exceptional entrepreneurs, institutional investors, and strategic partners who share our vision for building transformative technology companies that reshape global markets.

HQ
Global Headquarters

405 Hangang-daero, Yongsan District

Seoul 04509, South Korea

Phone: +82 (0)26 914 9377

Fax: +82 (0)26 951 1698

EN
For Entrepreneurs

Building breakthrough technology in semiconductors, displays, or biotechnology? We provide strategic expertise, industry connections, and operational support to accelerate your path to market leadership. Please include your executive summary, financial projections, and competitive analysis.

LP
For Limited Partners

Institutional investors seeking exposure to Asia's most promising technology sectors can access our comprehensive investor materials, performance data, and due diligence documentation through our secure LP portal.

Initiate Partnership Discussion

KOSPI $2,847.21 +1.24%
NASDAQ $18,567.19 +0.87%
SMH $267.45 +2.15%
XBI $94.83 -0.42%
VanEck Asia $67.29 +1.56%
Gold $2,024.80 +0.73%